New Planet Beer announced their sponsorship of Celiac Disease Foundation with the Win a Trip for Two to the 2014 CDF National Conference & Gluten-Free EXPO Sweepstakes. One lucky individual and guest will receive CDF National Conference & Gluten-Free EXPO registration, tickets to the Saturday night VIP Dinner with Dr. Alessio Fasano and Dr. John […]
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
Deborah Ceizler, CDF Chief Development Officer, recently attended the Development of Therapies for Celiac Disease Conference hosted by the Celiac Disease Center at Columbia University. The conference provided a unique opportunity to bring together experts from around the world – physicians, scientists, industry leaders including pharmaceutical, diagnostic, biotechnology and food & agriculture – and patients seeking […]
By Van Waffle | February 24, 2014 Despite a growing awareness of celiac disease, most people still don’t know they have it. When a pediatrician phoned Marilyn Geller with test results indicating her 15-year-old son probably had celiac disease, Geller did not understand what the physician was saying. With a master’s of science in public health […]
Dole Packaged Foods announced today that they are now a proud sponsor of Celiac Disease Foundation (CDF), a national nonprofit organization dedicated to driving early diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people affected by gluten-related disorders.
The Alcohol and Tobacco Tax and Trade Bureau (TTB) made a new ruling on how alcohol products can be labeled with respect to gluten. The TTB’s revised ruling on the matter, for the most part, is in line with the FDA.